Investor Video Call // August 04, 2026 // 2:00 p.m. CEST

Q2 2026 Results

Bayer operationally on track, decisive progress on strategic priorities

View Press ReleaseRecording of the Webcast
Q2-2026-Investor-Video-Call.png

Top row, from left to right: Bill Anderson, Chairman / Judith Hartmann, Finance / Stefan Oelrich, Pharmaceuticals

Lower row, from left to right: Rodrigo Santos, Crop Science / Julio Triana, Consumer Health 

board of management